The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...
The narrative is false that the COVID vaccine was rushed and not properly tested. It and other vaccines are safe and ...
The Feminist Majority Foundation, they were heroic. They collected over 700,000 petitions from people across the United ...
First Alert 4 on MSN5d
Nasal COVID vaccine developed at WashU approved for clinical trialsThe Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
On January 17, the Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) jointly published two final ...
The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback